1. Home
  2. FATE vs BVFL Comparison

FATE vs BVFL Comparison

Compare FATE & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • BVFL
  • Stock Information
  • Founded
  • FATE 2007
  • BVFL 1873
  • Country
  • FATE United States
  • BVFL United States
  • Employees
  • FATE N/A
  • BVFL N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • BVFL Savings Institutions
  • Sector
  • FATE Health Care
  • BVFL Finance
  • Exchange
  • FATE Nasdaq
  • BVFL Nasdaq
  • Market Cap
  • FATE 125.7M
  • BVFL 150.2M
  • IPO Year
  • FATE 2013
  • BVFL N/A
  • Fundamental
  • Price
  • FATE $1.15
  • BVFL $16.90
  • Analyst Decision
  • FATE Hold
  • BVFL
  • Analyst Count
  • FATE 7
  • BVFL 0
  • Target Price
  • FATE $3.58
  • BVFL N/A
  • AVG Volume (30 Days)
  • FATE 1.5M
  • BVFL 39.5K
  • Earning Date
  • FATE 08-12-2025
  • BVFL 10-20-2025
  • Dividend Yield
  • FATE N/A
  • BVFL N/A
  • EPS Growth
  • FATE N/A
  • BVFL 27.09
  • EPS
  • FATE N/A
  • BVFL 1.07
  • Revenue
  • FATE $8,470,000.00
  • BVFL $38,333,000.00
  • Revenue This Year
  • FATE N/A
  • BVFL N/A
  • Revenue Next Year
  • FATE N/A
  • BVFL N/A
  • P/E Ratio
  • FATE N/A
  • BVFL $15.74
  • Revenue Growth
  • FATE N/A
  • BVFL 2.48
  • 52 Week Low
  • FATE $0.66
  • BVFL $13.53
  • 52 Week High
  • FATE $4.20
  • BVFL $18.19
  • Technical
  • Relative Strength Index (RSI)
  • FATE 53.09
  • BVFL 70.29
  • Support Level
  • FATE $1.06
  • BVFL $16.13
  • Resistance Level
  • FATE $1.18
  • BVFL $16.57
  • Average True Range (ATR)
  • FATE 0.09
  • BVFL 0.28
  • MACD
  • FATE 0.02
  • BVFL 0.09
  • Stochastic Oscillator
  • FATE 72.73
  • BVFL 92.55

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: